Cargando…
Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China
BACKGROUND: The ongoing coronavirus disease 2019 (COVID-2019) pandemic has swept all over the world, posing a great pressure on critical care resources due to large number of patients needing critical care. Statements from front-line experts in the field of intensive care are urgently needed. METHOD...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275657/ https://www.ncbi.nlm.nih.gov/pubmed/32506258 http://dx.doi.org/10.1186/s13613-020-00689-1 |
_version_ | 1783542832264380416 |
---|---|
author | Shang, You Pan, Chun Yang, Xianghong Zhong, Ming Shang, Xiuling Wu, Zhixiong Yu, Zhui Zhang, Wei Zhong, Qiang Zheng, Xia Sang, Ling Jiang, Li Zhang, Jiancheng Xiong, Wei Liu, Jiao Chen, Dechang |
author_facet | Shang, You Pan, Chun Yang, Xianghong Zhong, Ming Shang, Xiuling Wu, Zhixiong Yu, Zhui Zhang, Wei Zhong, Qiang Zheng, Xia Sang, Ling Jiang, Li Zhang, Jiancheng Xiong, Wei Liu, Jiao Chen, Dechang |
author_sort | Shang, You |
collection | PubMed |
description | BACKGROUND: The ongoing coronavirus disease 2019 (COVID-2019) pandemic has swept all over the world, posing a great pressure on critical care resources due to large number of patients needing critical care. Statements from front-line experts in the field of intensive care are urgently needed. METHODS: Sixteen front-line experts in China fighting against the COVID-19 epidemic in Wuhan were organized to develop an expert statement after 5 rounds of expert seminars and discussions to provide trustworthy recommendation on the management of critically ill COVID-19 patients. Each expert was assigned tasks within their field of expertise to provide draft statements and rationale. Parts of the expert statement are based on epidemiological and clinical evidence, without available scientific evidences. RESULTS: A comprehensive document with 46 statements are presented, including protection of medical personnel, etiological treatment, diagnosis and treatment of tissue and organ functional impairment, psychological interventions, immunity therapy, nutritional support, and transportation of critically ill COVID-19 patients. Among them, 5 recommendations were strong (Grade 1), 21 were weak (Grade 2), and 20 were experts’ opinions. A strong agreement from voting participants was obtained for all recommendations. CONCLUSION: There are still no targeted therapies for COVID-19 patients. Dynamic monitoring and supportive treatment for the restoration of tissue vascularization and organ function are particularly important. |
format | Online Article Text |
id | pubmed-7275657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-72756572020-06-08 Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China Shang, You Pan, Chun Yang, Xianghong Zhong, Ming Shang, Xiuling Wu, Zhixiong Yu, Zhui Zhang, Wei Zhong, Qiang Zheng, Xia Sang, Ling Jiang, Li Zhang, Jiancheng Xiong, Wei Liu, Jiao Chen, Dechang Ann Intensive Care Review BACKGROUND: The ongoing coronavirus disease 2019 (COVID-2019) pandemic has swept all over the world, posing a great pressure on critical care resources due to large number of patients needing critical care. Statements from front-line experts in the field of intensive care are urgently needed. METHODS: Sixteen front-line experts in China fighting against the COVID-19 epidemic in Wuhan were organized to develop an expert statement after 5 rounds of expert seminars and discussions to provide trustworthy recommendation on the management of critically ill COVID-19 patients. Each expert was assigned tasks within their field of expertise to provide draft statements and rationale. Parts of the expert statement are based on epidemiological and clinical evidence, without available scientific evidences. RESULTS: A comprehensive document with 46 statements are presented, including protection of medical personnel, etiological treatment, diagnosis and treatment of tissue and organ functional impairment, psychological interventions, immunity therapy, nutritional support, and transportation of critically ill COVID-19 patients. Among them, 5 recommendations were strong (Grade 1), 21 were weak (Grade 2), and 20 were experts’ opinions. A strong agreement from voting participants was obtained for all recommendations. CONCLUSION: There are still no targeted therapies for COVID-19 patients. Dynamic monitoring and supportive treatment for the restoration of tissue vascularization and organ function are particularly important. Springer International Publishing 2020-06-06 /pmc/articles/PMC7275657/ /pubmed/32506258 http://dx.doi.org/10.1186/s13613-020-00689-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Shang, You Pan, Chun Yang, Xianghong Zhong, Ming Shang, Xiuling Wu, Zhixiong Yu, Zhui Zhang, Wei Zhong, Qiang Zheng, Xia Sang, Ling Jiang, Li Zhang, Jiancheng Xiong, Wei Liu, Jiao Chen, Dechang Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China |
title | Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China |
title_full | Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China |
title_fullStr | Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China |
title_full_unstemmed | Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China |
title_short | Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China |
title_sort | management of critically ill patients with covid-19 in icu: statement from front-line intensive care experts in wuhan, china |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275657/ https://www.ncbi.nlm.nih.gov/pubmed/32506258 http://dx.doi.org/10.1186/s13613-020-00689-1 |
work_keys_str_mv | AT shangyou managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT panchun managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT yangxianghong managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT zhongming managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT shangxiuling managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT wuzhixiong managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT yuzhui managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT zhangwei managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT zhongqiang managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT zhengxia managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT sangling managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT jiangli managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT zhangjiancheng managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT xiongwei managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT liujiao managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina AT chendechang managementofcriticallyillpatientswithcovid19inicustatementfromfrontlineintensivecareexpertsinwuhanchina |